Provided by Tiger Fintech (Singapore) Pte. Ltd.

Serina Therapeutics, Inc.

5.85
-0.2400-3.94%
Volume:10.89K
Turnover:62.37K
Market Cap:58.10M
PE:-3.86
High:6.03
Open:6.03
Low:5.44
Close:6.09
Loading ...
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 29, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Major Issues Report

Form 8-K - Current report
Jul 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Correspondence

Form CORRESP - Correspondence
Jul 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 03, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 15, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 15, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Major Issues Report

Form 8-K - Current report